MeSH Review:
Migraine Disorders
van Buchem,
Ganor,
Grant,
Martin,
Gobbi,
van den Maagdenberg,
Merikangas,
Ferrari,
Launer,
Pelliccioli,
Bousser,
Joutel,
Morley,
Iversen,
Scher,
Pietrobon,
Jes Olesen,
Wua,
Ashina,
Ducros,
Stipa,
Lescoat,
Montgomery,
Cahalon,
Sarchielli,
Frants,
Loder,
Denier,
Hershkovits,
Heath,
Tarducci,
Lipton,
Kim,
Dworetzky,
Cecillon,
Capocchi,
Nyholt,
Kruit,
Schifter,
Sari,
Burstein,
Ferreira,
Brain,
Alberti,
Strassman,
Tvedskov,
Kowa,
Lipka,
Jen,
Levy,
Levite,
Chowers,
Presciutti,
Darcel,
Medland,
Baloh,
Terwindt,
Vicaut,
Tournier-Lasserve,
Dudding,
Vahedi,
Besser,
Bigal,
Boomsma,
Scher,
Olesen,
Verschuren,
Blom,
- Migraine is a food-allergic disease. Monro, J., Carini, C., Brostoff, J. Lancet (1984)
- Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Wilmshurst, P.T., Nightingale, S., Walsh, K.P., Morrison, W.L. Lancet (2000)
- Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Koudstaal, P.J., Algra, A., Pop, G.A., Kappelle, L.J., van Latum, J.C., van Gijn, J. Lancet (1992)
- Nitric oxide is a key molecule in migraine and other vascular headaches. Olesen, J., Thomsen, L.L., Iversen, H. Trends Pharmacol. Sci. (1994)
- Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Greenshaw, A.J. Trends Pharmacol. Sci. (1993)
- Drug targets in stress-related disorders. Covelli, V., Passeri, M.E., Leogrande, D., Jirillo, E., Amati, L. Current medicinal chemistry. (2005)
- Serotonin1B receptors: from protein to physiological function and behavior. Sari, Y. Neuroscience and biobehavioral reviews. (2004)
- Comorbidity of migraine. Scher, A.I., Bigal, M.E., Lipton, R.B. Curr. Opin. Neurol. (2005)
- Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Levite, M., Chowers, Y., Ganor, Y., Besser, M., Hershkovits, R., Cahalon, L. Eur. J. Immunol. (2001)
- Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel, D., Lampen, A., Nau, H. Chem. Res. Toxicol. (2006)
- Vascular actions of calcitonin gene-related peptide and adrenomedullin. Brain, S.D., Grant, A.D. Physiol. Rev. (2004)
- The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. Ducros, A., Denier, C., Joutel, A., Cecillon, M., Lescoat, C., Vahedi, K., Darcel, F., Vicaut, E., Bousser, M.G., Tournier-Lasserve, E. N. Engl. J. Med. (2001)
- Migraine provoked by aspartame. Johns, D.R. N. Engl. J. Med. (1986)
- Diltiazem prophylaxis in refractory migraine. Smith, R., Schwartz, A. N. Engl. J. Med. (1984)
- Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon. Kahan, A., Weber, S., Amor, B., Guerin, F., Degeorges, M. N. Engl. J. Med. (1983)
- Treatment of migraine with metoprolol. Ljung, O. N. Engl. J. Med. (1980)
- Chenodeoxycholic acid in the prevention of migraine. Lévy, V.G., Nusinovici, V., Rosner, D., Darnis, F. N. Engl. J. Med. (1978)
- Vitamin C and migraine: a case report. Bali, L., Callaway, E. N. Engl. J. Med. (1978)
- Central serotonergic nerves project to the pial vessels of the brain. Edvinsson, L., Degueurce, A., Duverger, D., MacKenzie, E.T., Scatton, B. Nature (1983)
- Letter: Chocolate, beta-phenethylamine and migraine re-examined. Schweitzer, J.W., Friedhoff, A.J., Schwartz, R. Nature (1975)
- The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Olesen, J. Pharmacol. Ther. (2008)
- The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Lea, R., Colson, N., Quinlan, S., Macmillan, J., Griffiths, L. Pharmacogenet. Genomics (2009)
- Glycogenolysis induced by serotonin in brain: identification of a new class of receptor. Quach, T.T., Rose, C., Duchemin, A.M., Schwartz, J.C. Nature (1982)
- Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Moskowitz, M.A., Reinhard, J.F., Romero, J., Melamed, E., Pettibone, D.J. Lancet (1979)
- Genomewide significant linkage to migrainous headache on chromosome 5q21. Nyholt, D.R., Morley, K.I., Ferreira, M.A., Medland, S.E., Boomsma, D.I., Heath, A.C., Merikangas, K.R., Montgomery, G.W., Martin, N.G. Am. J. Hum. Genet. (2005)
- The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Lee, H.Y., Xu, Y., Huang, Y., Ahn, A.H., Auburger, G.W., Pandolfo, M., Kwiecinski, H., Grimes, D.A., Lang, A.E., Nielsen, J.E., Averyanov, Y., Servidei, S., Friedman, A., Van Bogaert, P., Abramowicz, M.J., Bruno, M.K., Sorensen, B.F., Tang, L., Fu, Y.H., Ptácek, L.J. Hum. Mol. Genet. (2004)
- Migraine and MTHFR C677T genotype in a population-based sample. Scher, A.I., Terwindt, G.M., Verschuren, W.M., Kruit, M.C., Blom, H.J., Kowa, H., Frants, R.R., van den Maagdenberg, A.M., van Buchem, M., Ferrari, M.D., Launer, L.J. Ann. Neurol. (2006)
- A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. van den Maagdenberg, A.M., Pietrobon, D., Pizzorusso, T., Kaja, S., Broos, L.A., Cesetti, T., van de Ven, R.C., Tottene, A., van der Kaa, J., Plomp, J.J., Frants, R.R., Ferrari, M.D. Neuron (2004)
- Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. MacIntyre, P.D., Bhargava, B., Hogg, K.J., Gemmill, J.D., Hillis, W.S. Circulation (1993)
- Function and dysfunction of synaptic calcium channels: insights from mouse models. Pietrobon, D. Curr. Opin. Neurobiol. (2005)
- Characterization of 5-hydroxytryptamine receptors in human temporal arteries: comparison between migraine suffers and nonsufferers. Skärby, T., Tfelt-Hansen, P., Gjerris, F., Edvinsson, L., Olesen, J. Ann. Neurol. (1982)
- Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Levy, D., Burstein, R., Strassman, A.M. Ann. Neurol. (2005)
- Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Del Zompo, M., Cherchi, A., Palmas, M.A., Ponti, M., Bocchetta, A., Gessa, G.L., Piccardi, M.P. Neurology (1998)
- Recent developments on KCNQ potassium channel openers. Wua, Y.J., Dworetzky, S.I. Current medicinal chemistry. (2005)
- No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Jen, J.C., Kim, G.W., Dudding, K.A., Baloh, R.W. Arch. Neurol. (2004)
- Genetics of migraine: an update with special attention to genetic comorbidity. Stam, A.H., van den Maagdenberg, A.M., Haan, J., Terwindt, G.M., Ferrari, M.D. Curr. Opin. Neurol. (2008)
- Tolfenamic acid is as effective as ergotamine during migraine attacks. Hakkarainen, H., Vapaatalo, H., Gothoni, G., Parantainen, J. Lancet (1979)
- Coronary angiography in migraine patient after subcutaneous sumatriptan. Evers, S., Husstedt, I.W., Enbergs, A. Lancet (1995)
- No increase of calcitonin gene-related peptide in jugular blood during migraine. Tvedskov, J.F., Lipka, K., Ashina, M., Iversen, H.K., Schifter, S., Olesen, J. Ann. Neurol. (2005)
- Functional 1H-MRS findings in migraine patients with and without aura assessed interictally. Sarchielli, P., Tarducci, R., Presciutti, O., Gobbi, G., Pelliccioli, G.P., Stipa, G., Alberti, A., Capocchi, G. Neuroimage (2005)
- Prophylaxis of menstrual migraine with triptans: problems and possibilities. Loder, E. Neurology (2002)